1. Murray PR, Rosenthal KS, Pfaller MA. Streptococcus and Enterococcus. Medical Microbiology, 9th edt, Elsevier, 2020: 191-209.
2. Winn W, Stephan A, Janda W. Koneman EW, Procop G, Schreckenberger P, Woods G. Koneman’s Color Atlas and Textbook of Diagnostic Microbiology: Baltimore, Philadelphia: Lippincott
Williams&Wilkins, 2006.
3. Schoch CL, Ciufo S, Domrachev M et al. NCBI Taxonomy: a comprehensive update on curation, resources and tools. Database (Oxford). 2020: baaa062.
4. Miller WR, Arias CA, Murray BE. Enterococcus Species, Streptococcus gallolyticus Group, and Leuconostoc Species. In Mandell, Douglas, and Bennett’s Principles and Practice of Infectious
Diseases. 9. Edt. Elsevier, 2019: 2492-2504.
5. Fisher K, Phillips C. The ecology, epidemiology and virulence of Enterococcus. Microbiology 2009; 155: 1749-1757
6. Teixeira LM, Carvalho MGS, Facklam RR, et al. Enterococcus. In: Murray PR, Baron EJ, Jorgen JH, et al, eds. Manual of Clinical Microbiology. 11th ed. Washington, DC: American Society
for Microbiology Press; 2015:403–421.
7. Upadhyyaya PMG, Ravikumar KL, Umapathy BL. Review of virulence factors of Enterococcus: a emerging nosocomial pathogen. Indian Journal of Medical Microbiology 2009;27(4): 301-305.
8. O’Toole RF, Leong KWC, Cumming V, Van Hal SJ. Vancomycin-resistant Enterococcus faecium and the emergence of new sequence types associated with hospital infection. Res Microbiol
2023;174(4):104046.
9. Eichel VM, Last K, Bruhwasser C, et al. “Epidemiology and outcomes of vancomycin-resistant enterococcus infections: a systematic review and meta-analysis.” Journal of Hospital Infection
2023; 141: 119-128.
10. Sadowy E. Mobile genetic elements beyond the VanB-resistance dissemination among hospital-associated enterococci and other Gram-positive bacteria. Plasmid 2021;114: 102558.
11. Calatrava E. Other Streptococcus Species and Enterococcus. In; Rezai N editor, Encyclopedia of Infection and Immunity. Elsevier 2022: 529-541.
12. Coburn PS, Gilmore M.S. The Enterococcus faecalis cytolysin: A novel toxin active against eukaryotic and prokaryotic cells. Cell Microbiol 2003; 5: 661–669.
13. Hallgren A, Claesson C, Saeedi B, et al. Molecular detection of aggregation substance, enterococcal surface protein, and cytolysin genes and in vitro adhesion to urinary catheters of Entero-
coccus faecalis and E.faecium of clinical origin. Int J Med Microbiol 2009, 299(5): 323-332.
14. Kayaoglu G, Orstavik D. Virulence factors of Enterococcus faecalis: relationship to endodontic disease. Crit Rev Oral Biol Med 2004; 15(5): 308-20.
15. Thomas VC, Thurlow LR, Boyle D, et al. Regulation of autolysis-dependent extracellular DNA release by Enterococcus faecalis extracellular proteases influences biofilm development. J Bacte-
riol. 2008; 190: 5690–5698.
16. Süßmuth SD, Muscholl-Silberhorn A, Wirth R, et al. Aggregation Substance Promotes Adherence, Phagocytosis, and Intracellular Survival of Enterococcus faecalis within Human Macropha-
ges and Suppresses Respiratory Burst. Infect. Immun 2000; 68: 4900–4906.
17. Hashem YA, Abdelrahman KA, Aziz RK. Phenotype–Genotype Correlations and Distribution of Key Virulence Factors in Enterococcus faecalis Isolated from Patients with Urinary Tract
Infections. Infect Drug Resist 2021; 14; 1713–1723.
18. Tendolkar PM, Baghdayan AS, Shankar N. The N-terminal domain of enterococcal surface protein, Esp,is sufficient for Esp-mediated biofilm enhancement in Enterococcus faecalis. J Bacteriol
2005; 187: 6213–6222.
19. Ch’ng JH, Chong KKL, Lam LN, et al Biofilm-associated infection by enterococci. Nat Rev Microbiol 2018; 17: 82–94.
20. Liu Q, Ponnuraj K, Xu Y, et al. The Enterococcus faecalis MSCRAMM ACE binds its ligand by the Collagen Hug model. J Biol Chem 2007; 282: 19629-19637.
21. Nallapareddy SR, Singh KV, Okhuysen PC, et al. A functional collagen adhesin gene, acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial
pathogen. Infect Immun 2008; 76: 4110-4119.
22. Huebner J, Quaas A, Krueger WA, et al. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect
Immun 2000; 68: 4631-4636.
23. Maekawa S, Yoshioka M, Kumamoto Y. Proposal of a new scheme for the serological typing of Enterococcus faecalis strains. Microbiol Immunol 1992; 36: 671-681.
24. Teng F, Jacques-Palaz KD, Weinstock GM, et al. Evidence that the enterococcal polysaccharide antigen gene (epa) cluster is widespread in Enterococcus faecalis and influences resistance to
phagocytic killing of E. faecalis. Infect Immun 2002;7 0: 2010-2015.
25. Nallapareddy SR, Singh KV, Sillanpaa J, et al. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J Clin Invest. 2006; 116: 2799-2807.
26. Krawczyk B, Wityk P, Gałęcka M, Michalik M. The Many Faces of Enterococcus spp. Commensal, Probiotic and Opportunistic Pathogen. Microorganisms 2021; 9(9): 1900.
27. Codelia-Anjum A, Lerner LB, Elterman D, et al. Enterococcal Urinary Tract Infections: A Review of the Pathogenicity, Epidemiology, and Treatment. Antibiotics (Basel). 2023; 12(4): 778.
28. Weiner LM, Webb AK, Limbago B, et al. Antimicrobial-Resistant Pathogens Associated With Healthcare-Associated Infections: Summary of Data Reported to the National Healthcare Safety
Network at the Centers for Disease Control and Prevention, 2011-2014. Infect Control Hosp Epidemiol 2016; 37(11): 1288-1301.
29. Fiore E, Van Tyne D, Gilmore MS. Pathogenicity of Enterococci. Microbiol Spectr 2019; 7(4):10.1128/microbiolspec.GPP3-0053-2018.
30. Anderson DJ, Murdoch DR, Sexton DJ et al. Risk factors for infective endocarditis in patients with enterococcal bacteremia: a case-control study. Infection 2004; 32: 72-77
31. Harbarth S, Uckay I. Are there patients with peritonitis who require empiric therapy for Enterococcus? Eur J Clin Microbiol Infect Dis 2004; 23: 73-77.
32. Higuita NIA, and Huycke MM. “Enterococcal disease, epidemiology, and implications for treatment In: Gilmore MS, Clewell DB, Ike Y, eds.” Enterococci: From commensals to leading causes
of drug resistant infection. Boston: Massachusetts Eye and Ear Infirmary 2014.
33. Goh HMS, Yong MHA, Chong KKL, Kline KA. Model systems for the study of Enterococcal colonization and infection. Virulence 2017; 8(8): 1525-1562.
34. Zhang X, Jiang C, Zhou C. Diagnosis of Enterococcus faecalis meningitis associated with long-term cerebrospinal fluid rhinorrhoea using metagenomics next-generation sequencing: a case
report. BMC Infect Dis 2021; 21(1): 1105.
35. Çay Ü, Alabaz D, Özgür Gündeşlioğlu Ö, et al. Experience with enterococcal meningitis/ventriculitis in children. Pediatr Int 2022; 65(1): e15398.
36. Mendes AR, Costa A, Ferreira H, Ferreira C. Enterococcus faecalis-associated lung abscess in a male adolescent- a case report. BMC Pediatr 2020; 20(1): 98.
37. Li F, Wang Y, Sun L, Wang X. Vancomycin-resistant Enterococcus faecium pneumonia in a uremic patient on hemodialysis: a case report and review of the literature. BMC Infect Dis 2020; 20:
167.
38. Clock SA, Jia H, Patel S, et al. Infant colonization with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci preceding neonatal intensive care unit discharge. J
Pediatric Infect Dis Soc 2017; 6: e144–e148.
39. Subramanya, S.H., Amberpet, R., Chaudhary, D. et al. Neonatal sepsis due to glycopeptide resistant Enterococcus faecium from colonized maternal gut- rare case evidence. Antimicrob Resist
Infect Control 2019; 8: 29.
40. Walker O, Kenny CB, Goel N. Neonatal sepsis. Paediatrics and Child Health 2019; 29(6): 263-268.
41. Shewmaker PL, Steigerwalt AG, Nicholson AC et al. Reevaluation of the taxonomic status of recently described species of Enterococcus: evidence that E. thailandicus is a senior subjective
synonym of E. sanguinicola and confirmation of E. caccae as a species distinct from E. silesiacus. J Clin Microbiol 2011; 49(7): 2676-2679.
42. Fang H, Ohlsson AK, Ullberg M, Ozenci V. Evaluation of species-specific PCR, Bruker MS, VITEK MS and the VITEK 2 system for the identification of clinical Enterococcus isolates. Eur J
Clin Microbiol Infect Dis 2012; 31(11): 3073.
43. Martinez RM, Bauerle ER, Fang FC, Butler-Wu SM. Evaluation of three rapid diagnostic methods for direct identification of microorganisms in positive blood cultures. J Clin Microbiol 2014;
52(7): 2521.
44. Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in Enterococcus. Virulence 2012; 3(5): 421-433.
45. Arias CA, Singh KV, Panesso D, et al. Evaluation of ceftobiprole medocaril against Enterococcus faecalis in a mouse peritonitis model. J Antimicrob Chemother 2007; 60: 594-598.
46. Kak V, Donabedian SM, Zervos MJ, et al. Efficacy of ampicillin plus arbekacin in experimental rabbit endocarditis caused by an Enterococcus faecalis strain with high-level gentamicin resis-
tance. Antimicrob Agents Chemother 2000; 44: 2545-2546.
47. Kawalec M, Gniadkowski M, Kedzierska J, Skotnicki A, Fiett J, Hryniewicz W. Selection of a teicoplanin-resistant Enteroccus faecium mutant during an outbreak caused by vancomycin-resis-
tant enterococci with the VanB phenotype. J Clin Microbiol 2001; 39: 4274-4282.
48. Yowler CJ, Blinkhorn RJ, Fratianne RB. Vancomycin-dependent enterococcal strains: case report and review. J Trauma 2000; 48: 783.
49. Herrero IA, Issa NC, Patel R. Nozocomial spread of linezolid-resistant, vancomycin-resistant Enterococcus faecium. N Engl J Med 2002; 346: 867-868.
50. McNeil SA, Clark NM, Chandrasekar PH, Kauffman CA. Successful treatment of persistent vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with
Synercid (qunipristin/dalfopristin). Clin Infect Dis 2000; 30: 403-404.
51. Arias CA, Panesso D, McGrath DM, et al. Genetic basis for in vivo daptomycin resistance in enterococci. N Engl J Med 2011; 365: 892-900.
52. Munita JM, Tran TT, Diaz L, et al. A liaF codon deletion abolishes daptomycin bactericidal activity against vancomycin-resistant Enterococcus faecalis. Antimicrob Agents Chemother 2013;
57: 2831-2833.
53. DiPippo AJ, Tverdek FP, Tarrand JJ, et al. Daptomycin non-susceptible Enterococcus faecium in leukemia patients: role of prior daptomycin exposure. J Infect 2017; 74: 243–247.
54. Ruiz-Ripa L, Feßler AT, Hanke D, et al. Mechanisms of Linezolid Resistance Among Enterococci of Clinical Origin in Spain-Detection of optrA- and cfr(D)-Carrying E.faecalis. Microorganis-
ms 2020; 8(8): 1155.
55. Beabout K, Hammerstrom TG, Perez AM, et al. The ribosomal S10 protein is a general target for decreased tigecycline susceptibility. Antimicrob Agents Chemother 2015; 59: 5561.
56. Khan A, Miller WR, Axell-House D, Munita JM, Arias CA. Antimicrobial Susceptibility Testing for Enterococci. J Clin Microbiol 2022; 60(9): e0084321.
57. Murray B, Miller W. Treatment of enterococcal infections. In UpToDate. Available online: https://www.uptodate.com/contents/treatment-of-enterococcal-infections (access date: 15.12.2023).
58. Shah KJ, Cherabuddi K, Shultz J, et al. Ampicillin for the treatment of complicated urinary tract infections caused by vancomycin-resistant Enterococcus spp (VRE): asingle-center university
hospital experience. Int J Antimicrob Agents 2018; 51: 57.
59. Baddour LM, Wilson WR, Bayer AS, et al. Infective Endocarditis in Adults: Diagnosis,Antimicrobial Therapy, and Management of Complications: A Scientific Statement for Healthcare Pro-
fessionals From the American Heart Association. Circulation 2015; 132: 1435.
60. Fernández-Hidalgo N, Almirante B, Gavaldà J, et al. Ampicillin plus ceftriaxone is aseffective as ampicillin plus gentamicin for treating enterococcus faecalis infectiveendocarditis. Clin Infect
Dis 2013; 56: 1261.
61. Kalfopoulou E, Huebner J. Advances and Prospects in Vaccine Development against Enterococci. Cells. 2020; 9(11): 2397.
62. Anderson DJ. Vancomycin-resistant enterococci: Epidemiology, prevention, and control. In UpToDate. Available online: https://www.uptodate.com/contents/vancomycin-resistant-entero-
cocci-epidemiology-prevention-and-control (access date: 15.12.2023).
63. Joshi S, Shallal A, Zervos M. Vancomycin-Resistant Enterococci: Epidemiology, Infection Prevention, and Control. Infect Dis Clin North Am 2021; 35(4): 953-968.